(S (PP (IN By) (NP (CD 2040))) (, ,) (NP (NP (ADJP (NN age) (HYPH -) (VBN related)) (JJ macular) (NN degeneration)) (-LRB- -LRB-) (NP (NNP AMD)) (-RRB- -RRB-)) (VP (MD will) (VP (VB affect) (NP (QP (RB approximately) (CD 288) (CD million)) (NNS people)) (ADVP (RB worldwide)))) (. .))
(S (S (VP (VBG Identifying) (NP (NNS individuals)) (PP (IN at) (NP (NP (JJ high) (NN risk)) (PP (IN of) (NP (NN progression))))) (PP (IN to) (NP (JJ late) (NNP AMD))))) (, ,) (NP (DT the) (ADJP (NP (NN sight)) (HYPH -) (VBG threatening)) (NN stage)) (, ,) (VP (VBZ is) (ADJP (JJ critical) (PP (IN for) (NP (JJ clinical) (NNS actions)))) (, ,) (PP (VBG including) (NP (NP (JJ medical) (NNS interventions)) (CC and) (NP (JJ timely) (NN monitoring))))) (. .))
(S (SBAR (IN Although) (S (NP (JJ deep) (NN learning)) (VP (VBZ has) (VP (VBN shown) (NP (NN promise)) (PP (IN in) (S (VP (VBG diagnosing) (, /) (VBG screening) (S (NP (NNP AMD)) (VP (VBG using) (NP (ADJP (NN color) (JJ fundus)) (NNS photographs))))))))))) (, ,) (NP (PRP it)) (VP (VBZ remains) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB predict) (NP (NP (NP (NNS individuals) (POS ')) (NNS risks)) (PP (IN of) (NP (JJ late) (NNP AMD)))) (ADVP (RB accurately))))))) (. .))
(S (PP (IN For) (NP (DT both) (NNS tasks))) (, ,) (NP (DT these) (JJ initial) (NML (JJ deep) (NN learning)) (NNS attempts)) (VP (VBP have) (VP (VBN remained) (S (ADJP (RB largely) (JJ unvalidated))) (PP (IN in) (NP (JJ independent) (NNS cohorts))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (WHADJP (WRB how) (JJ deep)) (S (NP (NML (NN learning) (CC and) (NN survival)) (NN analysis)) (VP (MD can) (VP (VB predict) (NP (NP (DT the) (NN probability)) (PP (IN of) (NP (NN progression)))) (PP (IN to) (NP (JJ late) (NNP AMD))) (S (VP (VBG using) (NP (NP (CD 3,298) (NNS participants)) (-LRB- -LRB-) (PP (IN over) (NP (CD 80,000) (NNS images))) (-RRB- -RRB-)) (PP (IN from) (NP (NP (DT the) (ADJP (NNP Age) (HYPH -) (NNP Related)) (NNP Eye) (NNP Disease) (NNPS Studies) (NNP AREDS)) (CC and) (NP (NP (NN AREDS2)) (, ,) (NP (DT the) (JJS largest))))) (NP-TMP (NP (JJ longitudinal) (JJ clinical) (NNS trials)) (PP (IN in) (NP (NNP AMD))))))))))) (. .))
(S (SBAR (WHADVP (WRB When)) (S (VP (VBN validated) (PP (IN against) (NP (NP (DT an) (JJ independent) (NN test) (NN dataset)) (PP (IN of) (NP (CD 601) (NNS participants)))))))) (, ,) (NP (PRP$ our) (NN model)) (VP (VBD achieved) (NP (NP (NP (JJ high) (JJ prognostic) (NN accuracy)) (-LRB- -LRB-) (NP (NML (CD five) (HYPH -) (NN year)) (NN C) (HYPH -) (NN statistic) (CD 86.4) (PRN (-LRB- -LRB-) (NP (NP (CD 95) (NN %)) (NP (NN confidence) (NN interval) (CD 86.2) (HYPH -) (CD 86.6))) (-RRB- -RRB-))) (-RRB- -RRB-)) (SBAR (WHNP (WDT that)) (S (ADVP (RB substantially)) (VP (VBD exceeded) (NP (NP (DT that)) (PP (IN of) (NP (JJ retinal) (NNS specialists)))) (S (VP (VBG using) (NP (CD two) (VBG existing) (JJ clinical) (NNS standards)))) (PRN (-LRB- -LRB-) (FRAG (FRAG (NP (CD 81.3)) (-LRB- -LRB-) (NP (CD 81.1) (SYM -) (CD 81.5)) (-RRB- -RRB-)) (CC and) (FRAG (NP (CD 82.0)) (-LRB- -LRB-) (NP (CD 81.8) (SYM -) (CD 82.3)) (-RRB- -RRB-))) (, ,) (ADVP (RB respectively)) (-RRB- -RRB-))))))) (. .))
(S (ADVP (RB Interestingly)) (, ,) (NP (PRP$ our) (NN approach)) (VP (VP (VBZ offers) (NP (NP (JJ additional) (NNS strengths)) (PP (IN over) (NP (NP (DT the) (VBG existing) (JJ clinical) (NNS standards)) (PP (IN in) (NP (NNP AMD) (NN prognosis)))))) (PRN (-LRB- -LRB-) (NP (NP (ADVP (FW e.g.)) (, ,) (NN risk) (NN ascertainment)) (PP (IN above) (NP (CD 50) (NN %)))) (-RRB- -RRB-))) (CC and) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (RB highly) (JJ generalizable)) (, ,) (PP (VBN given) (NP (NP (DT the) (NN breadth)) (PP (IN of) (NP (NP (NN training) (NNS data)) (PP (IN from) (NP (CD 82) (NNP US) (NML (JJ retinal) (NN specialty)) (NNS clinics))))))))))))) (. .))
(S (ADVP (RB Indeed)) (, ,) (PP (IN during) (NP (NP (JJ external) (NN validation)) (PP (IN through) (NP (NP (NN training)) (PP (IN on) (NP (NP (NN AREDS) (CC and) (NN testing)) (PP (IN on) (NP (NP (NN AREDS2)) (PP (IN as) (NP (DT an) (JJ independent) (NN cohort))))))))))) (, ,) (NP (PRP$ our) (NN model)) (VP (VBD retained) (NP (ADJP (RB substantially) (JJR higher)) (JJ prognostic) (NN accuracy)) (PP (IN than) (NP (VBG existing) (JJ clinical) (NNS standards)))) (. .))
(S (NP (DT These) (NNS results)) (VP (VBP highlight) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (NML (JJ deep) (NN learning)) (NNS systems)))) (S (VP (TO to) (VP (VB enhance) (NP (JJ clinical) (ADJP (ADJP (NN decision) (HYPH -) (VBG making)) (PP (IN in) (NP (NNP AMD)))) (NNS patients)))))) (. .))
